ASX:BDA

Stock Analysis Report

Executive Summary

Bod Australia Limited operates as a developer, manufacturer, distributor, and marketer of plant-based natural health supplements and beauty solutions in Australia.


Snowflake Analysis

Flawless balance sheet with weak fundamentals.

Share Price & News

How has Bod Australia's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: BDA's share price has been volatile over the past 3 months.


Market Performance


7 Day Return

44.4%

BDA

12.1%

AU Retail Distributors

13.4%

AU Market


1 Year Return

-40.9%

BDA

-18.1%

AU Retail Distributors

-18.8%

AU Market

Return vs Industry: BDA underperformed the Australian Retail Distributors industry which returned -18.1% over the past year.

Return vs Market: BDA underperformed the Australian Market which returned -18.8% over the past year.


Shareholder returns

BDAIndustryMarket
7 Day44.4%12.1%13.4%
30 Day-13.3%-25.7%-20.7%
90 Day-35.0%-30.4%-24.4%
1 Year-40.9%-40.9%-12.9%-18.1%-15.2%-18.8%
3 Year-30.4%-30.4%-6.4%-16.9%-2.8%-15.9%
5 Yearn/a58.7%21.3%9.3%-15.3%

Price Volatility Vs. Market

How volatile is Bod Australia's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Bod Australia undervalued compared to its fair value and its price relative to the market?

2.26x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate BDA's fair value to establish if it is undervalued.

Significantly Below Fair Value: Insufficient data to calculate BDA's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: BDA is unprofitable, so we can't compare its PE Ratio to the Retail Distributors industry average.

PE vs Market: BDA is unprofitable, so we can't compare its PE Ratio to the Australian market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate BDA's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: BDA is overvalued based on its PB Ratio (2.3x) compared to the AU Retail Distributors industry average (1.5x).


Next Steps

Future Growth

How is Bod Australia forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

8.2%

Forecasted Retail industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Bod Australia has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has Bod Australia performed over the past 5 years?

-46.6%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: BDA is currently unprofitable.

Growing Profit Margin: BDA is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: BDA is unprofitable, and losses have increased over the past 5 years at a rate of -46.6% per year.

Accelerating Growth: Unable to compare BDA's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: BDA is unprofitable, making it difficult to compare its past year earnings growth to the Retail Distributors industry (-2%).


Return on Equity

High ROE: BDA has a negative Return on Equity (-79.26%), as it is currently unprofitable.


Next Steps

Financial Health

How is Bod Australia's financial position?


Financial Position Analysis

Short Term Liabilities: BDA's short term assets (A$10.1M) exceed its short term liabilities (A$2.1M).

Long Term Liabilities: BDA's short term assets (A$10.1M) exceed its long term liabilities (A$433.8K).


Debt to Equity History and Analysis

Debt Level: BDA is debt free.

Reducing Debt: BDA had no debt 5 years ago.


Balance Sheet

Inventory Level: BDA has a low level of unsold assets or inventory.

Debt Coverage by Assets: Insufficient data to determine if BDA's debt is covered by short term assets.


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: BDA has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: BDA has sufficient cash runway for 1.2 years if free cash flow continues to reduce at historical rates of -54.1% each year.


Next Steps

Dividend

What is Bod Australia's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate BDA's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate BDA's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if BDA's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if BDA's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of BDA's dividend in 3 years as they are not forecast to pay a notable one for the Australian market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

2.6yrs

Average board tenure


CEO

Jo Patterson

no data

Tenure

AU$339,328

Compensation

Ms. Joanne Patterson, also known as Jo, MBus. (Marketing), serves as Chief Executive Officer of Bod Australia Limited. Ms. Patterson founded Bod Australia in 2014. Ms. Patterson is a strategic marketer wit ...


CEO Compensation Analysis

Compensation vs Market: Jo's total compensation ($USD209.01K) is about average for companies of similar size in the Australian market ($USD245.57K).

Compensation vs Earnings: Jo's compensation has increased whilst the company is unprofitable.


Board Members

NamePositionTenureCompensationOwnership
Joanne Patterson
CEO, Director & Member of Medical Advisory Boardno dataAU$339.33k6.35% A$957.0k
Craig Weller
COO & Member of Medical Advisory Board2.58yrsAU$283.60k6.29% A$948.7k
Adele Hosseini
Chief Scientific Officer & Member of Medical Advisory Board2.58yrsno datano data
Simon O'Loughlin
Independent Non-Executive Director3.58yrsAU$39.24k1.27% A$191.4k
Mark Masterson
Non-Executive Chairman0.25yrno data0.48% A$72.8k
Patrice Malard
Independent Non-Executive Director0.67yrno datano data
George Livery
Non-Executive Director1.42yrsAU$413.64k0.37% A$56.1k
Stella Valenzuela
Member of Medical Advisory Board2.58yrsno datano data
Nick Burgess
Member of Medical Advisory Board2.58yrsno datano data
Akash Bedi
Independent Non-Executive Director0.67yrno datano data

2.6yrs

Average Tenure

61yo

Average Age

Experienced Board: BDA's board of directors are not considered experienced ( 2.6 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 32.3%.


Top Shareholders

Company Information

Bod Australia Limited's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Bod Australia Limited
  • Ticker: BDA
  • Exchange: ASX
  • Founded:
  • Industry: Distributors
  • Sector: Retail
  • Market Cap: AU$15.076m
  • Shares outstanding: 91.37m
  • Website: https://bodaustralia.com

Location

  • Bod Australia Limited
  • 377 New South Head Road
  • Level 1
  • Double Bay
  • New South Wales
  • 2028
  • Australia

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
BDAASX (Australian Securities Exchange)YesOrdinary SharesAUAUDOct 2016
BDACHIA (Chi-X Australia)YesOrdinary SharesAUAUDOct 2016

Biography

Bod Australia Limited operates as a developer, manufacturer, distributor, and marketer of plant-based natural health supplements and beauty solutions in Australia. The company also develops a range of over the counter and therapeutic products. Bod Australia Limited has research collaboration agreements with Cannabis Access Clinics; and the University of South Australia to conduct additional research on MediCabilis products. The company is based in Double Bay, Australia. 


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/03/31 11:08
End of Day Share Price2020/03/31 00:00
Earnings2019/12/31
Annual Earnings2019/06/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.